Last edition
News about "Biochemical response"
Zydus Reports Positive Phase 3 Results for Saroglitazar in Primary Biliary Cholangitis
The study met its primary endpoint, showing a 48.5% treatment difference in biochemical response with Saroglitazar 1 mg compared to placebo (P<0.001). Biochemical response was defined by improvement in alkaline phosphatase (ALP) and bilirubin, key markers of PBC progression.
Biochemical Response | 29/08/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members